How US antitrust can be on target : the brand-name pescription drug litigation
Year of publication: |
1997
|
---|---|
Authors: | Weinstein, Roy |
Other Persons: | Culbertson, John (contributor) |
Published in: |
International journal of the economics of business. - Abingdon, Oxfordshire : Routledge, ISSN 1357-1516, ZDB-ID 1196953-2. - Vol. 4.1997, 3, p. 257-264
|
Subject: | Pharmahandel | Pharmaceutical distributors | Wettbewerbsbeschränkung | Restraints of competition | Preisdifferenzierung | Price discrimination | Wettbewerbspolitik | Competition policy | USA | United States |
-
Cartels, spontaneous price discrimination and international pharmacy retailing
Reekie, W. Duncan, (1997)
-
How US antitrust can go astray : the brand name pescription drug litigation
Scherer, Frederic M., (1997)
-
How US antitrust can go astray : the brand name prescription drug litigation
Scherer, Frederic M., (1997)
- More ...
-
How US Antitrust Can Be On Target: The Brand-Name Prescription Drug Litigation
Weinstein, Roy, (1997)
-
How US Antitrust Can Be On Target: The Brand Name Prescription Drug Litigation
Weinstein, Roy, (1997)
-
What ever happened to space spin-off?
Culbertson, John, (1968)
- More ...